Results 31 to 40 of about 13,036 (233)

Gentian violet for pyoderma gangrenosum: a retrospective chart review [PDF]

, 2020
Pyoderma gangrenosum is a rare autoinflammatory skin disease. Treatment is multifactorial, addressing inflammation, pain, underlying disease, if present, and the wound.
Cline, A, Feldman, SR, Glines, KR, Huang, WW, Jorizzo, JL, Muse, ME, Stiff, KM   +6 more
core  

Pyoderma Gangrenosum Associated with Sclerosing Cholangitis, Type 1 Diabetes Mellitus and Ulcerative Colitis [PDF]

, 2001
We describe the case of a 22-year-old black female with type 1 diabetes mellitus diagnosed when she was 12 years old. She first presented (March 1994) with pustules and ulcerations on the upper and lower limbs, trunk and scalp at the age 17.
A Morbey, Basler, Bastin, Bretagne, Cairns, Callen, Callen, F Assis Pacheco, F Fonseca, F Pereira, Greenberger, Greenstein, Hickman, Hohenleutner, Holt, Kaplan, Lim, M Goreti Catorze, Magro, O'Loughlin, Olsson, Philpott, Powell, Schwaegerle, Shelley, Stathers, Thornton, Warren, Wolf   +28 more
core   +1 more source

Nicotine for Pyoderma Gangrenosum [PDF]

Archives of Dermatology, 1998
A 35-year-old man with no past medical illness developed bloody diarrhea with up to 12 loose stools per day and abdominal pain in February 1984. He had smoked 1 pack of cigarettes per day for 16 years until he stopped smoking 2 months prior to the onset of his illness.
WOLF R., RUOCCO, Vincenzo
openaire   +3 more sources

A case of pyoderma gangrenosum around the urethral meatus aggravated by COVID‐19 infection and further worsened due to the development of pyogenic osteomyelitis 8 years after urostomy

Clinical Case Reports, 2023
Key Clinical Message After the infection with COVID‐19, pyoderma gangrenosum worsened and further led to necrosis following pyogenic osteomyelitis. Infection is a major exacerbating factor in pyoderma gangrenosum.
Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Koji Habe, Keiichi Yamanaka   +4 more
doaj   +1 more source

Ciclosporin compared to prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial [PDF]

, 2017
Background Pyoderma gangrenosum (PG) is a painful, ulcerating skin disease with poor evidence for management. Prednisolone and ciclosporin are the most commonly used treatments, although not previously compared within a randomised controlled trial ...
Billingham, Binus, Brooklyn, Brooklyn, Claxton, Craig, Dolan, Drummond, Faria, Finlay, Husereau, Kind, Krawzik, Langan, Manca, Miller, Ormerod, Raftery, Reichrath, Sculpher, Sterne, Su, Tremezaygues, White, White, Willan, Zuo   +26 more
core   +4 more sources

Research progress in pathogenesis of the pyoderma gangrenousum

Pifu-xingbing zhenliaoxue zazhi, 2022
Pyoderma gangrenosum (PG) is a neutrophilic dermatosis with unknown origin. Genetic factors, neutrophil dysfunction, complement system dysregulation and aberrant cytokine secretion play important parts in its pathogenesis. This article will make a review
Xiaoli LI, Naiyu LIN, Xuhua TANG, Jiande HAN   +3 more
doaj   +3 more sources

A Rare Case of Pyoderma Gangrenosum in a HIV Positive Patient

Asian Journal of Medical Sciences, 2011
HIV infection can lead to varied spectrum of associated disease conditions. Pyoderma gangrenosum is a neutrophilic dermatosis that may be associated with myeloid malignancies.
Eswari Loganathan
doaj   +1 more source

Pyoderma Gangrenosum: A Retrospective Study of Clinical Charac­teristics, Comorbidities, Response to Treatment and Mortality Related to Prednisone Dose

Acta Dermato-Venereologica, 2021
Pyoderma gangrenosum is an uncommon ulcerative neutrophilic dermatosis. Clinical presentation, location and associated diseases are diverse. Treatment of pyoderma gangrenosum includes treating the underlying comorbidity supplemented with topical and/or ...
Louise Schøsler, Karsten Fogh, Rikke Bech   +2 more
doaj   +1 more source

A case of ulcerative colitis presenting as pyoderma gangrenosum and lung nodule [PDF]

, 2014
Pyoderma gangrenosum is a phenomenon of cutaneous ulceration where etiology is not well understood. About half of the cases have an associated extracutanoeus manifestation or associated systemic diseases.
Subhash Chandra, Xin Li
core   +1 more source

Gene therapy for pyoderma gangrenosum: optimal transfection conditions and effect of drugs on gene delivery in the HaCaT cell line using cationic liposomes [PDF]

, 2016
Background/Aims: Pyoderma gangrenosum (PG) is a rare ulcerative skin disease, currently treated empirically with immunosuppression. PG is a good target for gene therapy since the skin is easily accessible.
Birchall, James Caradoc, Hargest, Rachel, Teagle, Alexandra R.   +2 more
core   +2 more sources